Simvastatin plus Rifaximin to prevent ACLF in patients with decompensated cirrhosis. A randomised, double-blind, placebo-controlled, phase-3 trial: the liverhope efficacy trial
Year: 2023
Type: article
Source: Journal of Hepatology
Authors: Elisa Pose, César Jiménez, Giacomo Zaccherini, Daniela Campion, Salvatore Piano, Frank Erhard Uschner, Koos de Wit, Olivier Roux, Kohilan Gananandan, Wim Laleman, Cristina Solé, Sonia Alonso, Berta Cuyas, Xavier Ariza, Adria Juanola, Ann T Ma, Laura Napoleone, Jordi Gratacos, Marta Tonon, Enrico Pompili, Jordi Sánchez-Delgado, Marta Carol, Martina Perez, Núria Fabrellas, Judit Pich, Claudia Martell, Georgina Casanovas, Gemma Domenech, Ferran Torres, Víctor Manuel, Vargas Blasco, Paolo Caraceni, Carlo Alessandria, Paolo Angeli, Jonel Trebicka, Ulrich Beuers, Claire Francoz, Raj Mookerjee, Rafael Bañares, German Soriano, Ruben Hernaez, Andrew S. Allegretti, Manuel Morales-Ruiz, Miquel Serra, Hugh Watson, Juan G Abraldes, Patrick S. Kamath, Pere Ginès
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4384941565